Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonis Antoniou

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Epidemiology|August 27, 2024
Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancerSuzana A M Ezquina, Michelle Jones, Ed Dicks, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured InterviewsFaiza Gaba, Samuel Oxley, Xinting Liu, et al.
Lancet (London, England)|May 24, 2025
Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trialFiona J Gilbert, Nicholas R Payne, Iris Allajbeu, et al.
BMJ Open|May 2, 2025
Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional studyArian Omeranovic, Julie Lapointe, Philippe Fortier, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
Journal of Medical Genetics|April 3, 2021
Characterisation of protein-truncating and missense variants in <i>PALB2</i> in 15 768 women from Malaysia and SingaporePei Sze Ng, Rick Acm Boonen, Eldarina Wijaya, et al.
Human Genetics|February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Epidemiology|August 27, 2024
Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancerSuzana A M Ezquina, Michelle Jones, Ed Dicks, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured InterviewsFaiza Gaba, Samuel Oxley, Xinting Liu, et al.
Lancet (London, England)|May 24, 2025
Comparison of supplemental breast cancer imaging techniques-interim results from the BRAID randomised controlled trialFiona J Gilbert, Nicholas R Payne, Iris Allajbeu, et al.
BMJ Open|May 2, 2025
Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional studyArian Omeranovic, Julie Lapointe, Philippe Fortier, et al.
Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
Journal of Medical Genetics|April 3, 2021
Characterisation of protein-truncating and missense variants in <i>PALB2</i> in 15 768 women from Malaysia and SingaporePei Sze Ng, Rick Acm Boonen, Eldarina Wijaya, et al.
Human Genetics|February 28, 2019
A response to "Personalised medicine and population health: breast and ovarian cancer"Antonis Antoniou, Hoda Anton-Culver, Alexander Borowsky, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Pageof 4